+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gadodiamide Market - Global Forecast 2025-2030- Product Image
Gadodiamide Market - Global Forecast 2025-2030- Product Image
Sale

Gadodiamide Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129140
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gadodiamide market is evolving rapidly, driven by advances in imaging technology, significant regulatory updates, and the need for greater diagnostic clarity in clinical care. Senior leaders considering investments or operational strategy in this sector must evaluate shifting supply chain dynamics and competitive developments as innovation reshapes market direction.

Gadodiamide Market Snapshot

The global gadodiamide market is transitioning from traditional usage patterns as healthcare providers and suppliers adapt to new clinical and regulatory demands. Recent technological updates in MRI platforms, especially ultrahigh field-strength scanners, are expanding utilization in both established and emerging regional healthcare systems. This market is witnessing streamlined workflows in diagnostic centers and hospitals, reflecting a shift toward value-based care and enhanced patient outcomes. Strategic collaborations, regional production, and evolving regulatory frameworks continue to redefine the competitive landscape and stakeholder roles.

Scope & Segmentation

This research report provides in-depth coverage across products, applications, end user profiles, and global geographies. Key segments include:

  • Product Types: Branded and generic gadodiamide formulations.
  • Clinical Applications:
    • Body imaging: Abdominal, breast, and pelvic MRI
    • Cardiovascular imaging: Cardiac MRI, arterial, and venous vascular assessments
    • Central nervous system imaging: Brain and spinal cord MRI
    • Musculoskeletal imaging: Bone marrow and joint visualization
  • End User Segments: Ambulatory surgical centers, clinics, diagnostic imaging centers, and hospitals.
  • Dose Forms: Pre-filled syringes and vials for tailored clinical administration.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), EMEA (including United Kingdom, Germany, France, Russia, Middle East, Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and Southeast Asia).
  • Technology Drivers: Advanced MRI hardware, artificial intelligence for image analysis, and green chemistry in formulation and production.

Key industry players analyzed include GE HealthCare Technologies, Sagent Pharmaceuticals, Litha Healthcare Group, Teva Pharmaceutical, Sandoz International, Mallinckrodt, Dr. Reddy’s Laboratories, Aurobindo Pharma, Sun Pharmaceutical, and Cadila Healthcare.

Key Takeaways

  • Gadodiamide remains central to MRI workflows for enhancing image clarity across diverse clinical settings, supporting radiologists in detecting subtle anatomical changes and pathologies.
  • Product differentiation between branded and generic agents is shaping procurement decisions, as organizations balance reliability and cost-efficiency in routine and complex imaging scenarios.
  • Application areas now encompass both routine outpatient imaging and advanced modalities in oncology, neurology, and musculoskeletal diagnostics, expanding the solution’s market reach.
  • Collaborations between major pharmaceutical firms, biotechnology startups, and academic partners drive innovation in dosage forms and administration protocols, promoting adoption in high-growth regions.
  • Sustainable manufacturing methods and supply chain transparency are gaining traction, as value-based care models require contrast agents that minimize risk without sacrificing efficacy.
  • Proactive pharmacovigilance, rigorous quality control, and compliance with region-specific regulatory guidelines remain key imperatives for all market participants.

Tariff Impact

Recent United States tariff adjustments on imported gadodiamide raw materials are influencing supply chain strategies and cost structures. Manufacturers increasingly explore local sourcing and alternate supplier networks to manage new cost pressures. The industry response includes deploying contingency plans, renegotiating with distributors, and adopting transparent cost models. This climate encourages resilient inventory management, geographic supply diversification, and greater collaboration between manufacturers and downstream partners.

Methodology & Data Sources

This report employs a rigorous research framework combining primary engagement with clinical, regulatory, and procurement stakeholders and robust secondary analysis. Data sources include in-depth interviews, peer-reviewed literature, regulatory filings, and industry white papers. Findings are validated using a triangulation approach and expert peer review, ensuring credible and actionable market intelligence.

Why This Report Matters

  • Provides strategic insight for manufacturers, distributors, and healthcare providers to optimize product portfolios and supply chain planning in the gadodiamide sector.
  • Helps decision-makers anticipate regulatory changes, emerging clinical opportunities, and the impact of evolving procurement models on market adoption.
  • Equips leaders with actionable intelligence on market segmentation, technology trends, and competitive positioning for sustained growth.

Conclusion

The gadodiamide market is defined by rapid technological progress, shifting regulations, and the continual demand for diagnostic accuracy. Leadership teams that respond proactively to these trends are best positioned to realize strategic advantages and long-term value in this dynamic field.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising regulatory scrutiny over linear gadolinium contrast agents due to NSF concerns
5.2. Shift in hospital purchasing toward macrocyclic gadolinium agents as safety concerns mount
5.3. Emerging research on gadodiamide deposition in neural tissues prompting market reevaluation
5.4. Increasing adoption of alternative imaging modalities reducing reliance on gadodiamide contrast
5.5. Regional market growth in Asia-Pacific driven by expanding MRI infrastructure and aging population
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gadodiamide Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Gadodiamide Market, by Application
9.1. Introduction
9.2. Body Imaging
9.2.1. Abdominal MRI
9.2.2. Breast MRI
9.2.3. Pelvic MRI
9.3. Cardiovascular Imaging
9.3.1. Cardiac MRI
9.3.2. Vascular Imaging
9.3.2.1. Arterial Imaging
9.3.2.2. Venous Imaging
9.4. Central Nervous System Imaging
9.4.1. Brain Imaging
9.4.2. Spinal Cord Imaging
9.5. Musculoskeletal Imaging
9.5.1. Bone Marrow Imaging
9.5.2. Joint Imaging
10. Gadodiamide Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Imaging Centers
10.5. Hospitals
11. Gadodiamide Market, by Dose Form
11.1. Introduction
11.2. Pre-Filled Syringes
11.3. Vials
12. Americas Gadodiamide Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gadodiamide Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gadodiamide Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. GE HealthCare Technologies, Inc.
15.3.2. Sagent Pharmaceuticals, Inc.
15.3.3. Litha Healthcare Group, Inc.
15.3.4. Teva Pharmaceutical Industries Limited
15.3.5. Sandoz International GmbH
15.3.6. Mallinckrodt plc
15.3.7. Dr. Reddy’s Laboratories Limited
15.3.8. Aurobindo Pharma Limited
15.3.9. Sun Pharmaceutical Industries Limited
15.3.10. Cadila Healthcare Limited
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. GADODIAMIDE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GADODIAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GADODIAMIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GADODIAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GADODIAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GADODIAMIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GADODIAMIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GADODIAMIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GADODIAMIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GADODIAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GADODIAMIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GADODIAMIDE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GADODIAMIDE MARKET: RESEARCHAI
FIGURE 24. GADODIAMIDE MARKET: RESEARCHSTATISTICS
FIGURE 25. GADODIAMIDE MARKET: RESEARCHCONTACTS
FIGURE 26. GADODIAMIDE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GADODIAMIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GADODIAMIDE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GADODIAMIDE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GADODIAMIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GADODIAMIDE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GADODIAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GADODIAMIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GADODIAMIDE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GADODIAMIDE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GADODIAMIDE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GADODIAMIDE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GADODIAMIDE MARKET SIZE, BY BODY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GADODIAMIDE MARKET SIZE, BY BODY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GADODIAMIDE MARKET SIZE, BY ABDOMINAL MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GADODIAMIDE MARKET SIZE, BY ABDOMINAL MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GADODIAMIDE MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GADODIAMIDE MARKET SIZE, BY BREAST MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GADODIAMIDE MARKET SIZE, BY PELVIC MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GADODIAMIDE MARKET SIZE, BY PELVIC MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GADODIAMIDE MARKET SIZE, BY CARDIAC MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GADODIAMIDE MARKET SIZE, BY CARDIAC MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GADODIAMIDE MARKET SIZE, BY ARTERIAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GADODIAMIDE MARKET SIZE, BY ARTERIAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GADODIAMIDE MARKET SIZE, BY VENOUS IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GADODIAMIDE MARKET SIZE, BY VENOUS IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GADODIAMIDE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GADODIAMIDE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GADODIAMIDE MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GADODIAMIDE MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GADODIAMIDE MARKET SIZE, BY BONE MARROW IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GADODIAMIDE MARKET SIZE, BY BONE MARROW IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GADODIAMIDE MARKET SIZE, BY JOINT IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GADODIAMIDE MARKET SIZE, BY JOINT IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GADODIAMIDE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GADODIAMIDE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GADODIAMIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GADODIAMIDE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GADODIAMIDE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GADODIAMIDE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GADODIAMIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GADODIAMIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GADODIAMIDE MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GADODIAMIDE MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GADODIAMIDE MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GADODIAMIDE MARKET SIZE, BY VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS GADODIAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS GADODIAMIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES GADODIAMIDE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES GADODIAMIDE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 118. CANADA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 119. CANADA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 120. CANADA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 121. CANADA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 122. CANADA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 123. CANADA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 124. CANADA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 125. CANADA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 126. CANADA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 127. CANADA GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. CANADA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 130. CANADA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 131. MEXICO GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 136. MEXICO GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 137. MEXICO GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 138. MEXICO GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 139. MEXICO GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 140. MEXICO GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 141. MEXICO GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 142. MEXICO GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 143. MEXICO GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 144. MEXICO GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 145. MEXICO GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 148. MEXICO GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GADODIAMIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 223. GERMANY GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 228. GERMANY GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 229. GERMANY GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 230. GERMANY GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 231. GERMANY GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 232. GERMANY GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 233. GERMANY GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 234. GERMANY GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 235. GERMANY GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 236. GERMANY GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 237. GERMANY GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. GERMANY GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. GERMANY GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 240. GERMANY GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 241. FRANCE GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. FRANCE GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. FRANCE GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 246. FRANCE GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 247. FRANCE GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 248. FRANCE GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 249. FRANCE GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 250. FRANCE GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 251. FRANCE GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 252. FRANCE GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 253. FRANCE GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 254. FRANCE GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 255. FRANCE GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FRANCE GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. FRANCE GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 258. FRANCE GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 277. ITALY GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. ITALY GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. ITALY GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 282. ITALY GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 283. ITALY GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 284. ITALY GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 285. ITALY GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 286. ITALY GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 287. ITALY GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 288. ITALY GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 289. ITALY GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 290. ITALY GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 291. ITALY GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. ITALY GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. ITALY GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 294. ITALY GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 295. SPAIN GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SPAIN GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SPAIN GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SPAIN GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SPAIN GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 300. SPAIN GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 301. SPAIN GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 302. SPAIN GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 303. SPAIN GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 304. SPAIN GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 305. SPAIN GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 306. SPAIN GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 307. SPAIN GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 308. SPAIN GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 309. SPAIN GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SPAIN GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SPAIN GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 312. SPAIN GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM IMAGING, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY MUSCULOSKELETAL IMAGING, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA GADODIAMIDE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2018-2024 (USD MILLION)
TABLE 354. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY BODY IMAGING, 2025-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 356. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA GADODIAMIDE MARKET SIZE, BY VASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 358. SOUTH AFRICA GA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gadodiamide Market report include:
  • GE HealthCare Technologies, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Litha Healthcare Group, Inc.
  • Teva Pharmaceutical Industries Limited
  • Sandoz International GmbH
  • Mallinckrodt plc
  • Dr. Reddy’s Laboratories Limited
  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Limited
  • Cadila Healthcare Limited

Related Reports

Gadolinium Contrast Media Market - Global Forecast 2025-2030 - Product Image

Gadolinium Contrast Media Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
MRI Contrast Media Market Report 2025 - Product Image

MRI Contrast Media Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gadopentetate Dimeglumine Market - Global Forecast 2025-2030 - Product Image

Gadopentetate Dimeglumine Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region - Global Forecast to 2030 - Product Image

MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region - Global Forecast to 2030

  • Report
  • 260 Pages
  • Global
From
Whole Body Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Nuclear Imaging), By Application (Oncology, Trauma And Emergency Care, Metastasis Detection), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Whole Body Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Nuclear Imaging), By Application (Oncology, Trauma And Emergency Care, Metastasis Detection), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.